Drug details
Clolar (clofarabine)
type of Antineoplastics, Antimetabolite
Clolar (clofarabine) is a cancer (antineoplastic) medication used to treat acute lymphoblastic leukemia (a type of blood cancer) in children and young adults up to 21 years old. Clolar is usually given after other cancer medicines have been tried without successful treatment.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- upper stomach pain,
- dark urine,
- vomiting,
- diarrhea,
- fever,
- easy bruising,
- unusual bleeding,
- pale skin,
- lightheadedness,
- shortness of breath,
- cold hands and feet,
- chills,
- rapid breathing,
- tiredness,
- yellowing of the skin or eyes (jaundice),
- chest pain,
- severe headache,
- flu-like symptoms,
- weakness,
- sore throat,
- burning eyes,
- skin pain,
- red or purple skin rash with blistering and peeling,
- little or no urination,
- shallow breathing,
- muscle cramps,
- sudden numbness or weakness (especially on one side of the body),
- bloody or tarry stools,
- coughing up blood,
- skin sores,
- diarrhea that is watery or bloody,
- blood in your urine,
- sudden swelling,
- trouble breathing while laying down,
- pain, blisters, bleeding, or severe rash on the palms of your hands or the soles of your feet,
- sudden swelling of your mid-section,
- mouth or throat ulcers,
- problems with vision or speech,
- fast or slow heart rate, and
- tingling in your hands, feet, or around your mouth
The following drugs are related to Clolar, either as a replacement or used together:
- Rylaze (asparaginase erwinia chrysanthemi (recombinant) - rywn) injection)
- Inqovi (decitabine and cedazuridine tablets)
- Nivestym (filgrastim-aafi injection)
- Lumoxiti (moxetumomab pasudotox-tdfk for injection)